Getting a Clear View : Lessons From The CLARITY-BPA Study, 2019
Listen to Dr. Laura Vandenberg, Associate Professor and Graduate Program Director in the Department of Environmental Health Sciences in the University of Massachusetts Amherst School of Public Health and Health Sciences, analyses The CLARITY-BPA study. Reference.
Bisphenol A (BPA) is produced in high volume and is still in use in a variety of products globally. Many independent, academic studies have demonstrated an association between exposure to BPA and multiple adverse health outcomes including endocrine-disrupting end-points. However, studies included in regulatory risk assessments have been cited as evidence that current uses of BPA are safe.
The U.S. National Institute of Environmental Health Sciences (NIEHS), the National Toxicology Program (NTP), and the Food and Drug Administration (FDA) sought to address these disparities in scientific findings and put together the Consortium Linking Academic and Regulatory Insights on BPA Toxicity, otherwise known as CLARITY-BPA.
2013 Report of the Interagency Breast Cancer and Environmental Research Coordinating Committee
The February 2013 Congressional Mandated Committee report from the National Institutes of Health recommended a national strategy that shifts the focus of breast cancer research from diagnosis and treatment to the causes and prevention. An overview:
Breast Cancer Burden
Major Advances in Breast Cancer Prevention, Diagnosis, and Treatment
State of the Science: Part 1 – Principles, Approach, and Mechanisms
State of the Science: Part 2 – Evidence From Animal and Human Studies and CrossCutting Themes
Research Translation, Dissemination, and Communication of Research Related to Breast Cancer and the Environment: From Science to Society and Back Again